Log In
BCIQ
Print this Print this
 

Duligotuzmab (MEHD7945A, RG7597)

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionHumanized IgG1 mAb targeting EGFR and HER3
Molecular Target Epidermal growth factor receptor (EGFR) ; Erb-b2 receptor tyrosine kinase 3 (ERBB3) (HER3) (EGFR3)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today